This retrospective cohort study using Japanese claims data included 13797 pregnant women with hypertension. The study period was divided into three terms to evaluate the influence of regulatory actions. Significant changes were identified in the trend of prescription proportions of nifedipine and hydralazine, but not in pregnancy outcomes.
- Reina Taguchi
- Daisuke Shigemi
- Hideo Yasunaga
